Apoptotic pathways are initiated as a cellular defense mechanism to eliminate adenovirus-infected cells. We have investigated how E1A-induced apoptosis interferes with viral replication in cancer cells. We found that E1B19K alone can efficiently suppress E1A-induced apoptosis in cancer cells. Viruses deleted for both E1B19K and E1B55K resulted in cellular DNA degradation. However, less than 20% of human lung cancer cells infected with a virus deleted for both E1B19K and E1B55 K had evidence of chromatin condensation and multiple-micronuclei formation (apoptotic hallmarks); these cells could not produce infectious viral particles. The majority of cancer cells infected with viruses deleted for the entire E1b gene did not undergo extended apoptosis and produced abundant viral progeny. Thus, only a fraction of cancer cells underwent apoptosis and did not allow E1b-deleted viruses to replicate, while the majority of cancer cells were resistant to E1A-induced apoptosis and could support virus-selective replication. The results of this study imply that, in addition to inhibiting E1A-induced apoptosis, E1B proteins may contribute other important roles in the viral life cycle. Our results also suggest that combining virus-induced apoptosis and selective viral replication into one vector will be a novel approach to destroy cancer cells.
T o induce the cells into S-phase for effective viral propagation, adenoviral E1A proteins bind to members of the retinoblastoma (Rb) protein of a tumor suppressor family. Sequestration of Rb protein by the E1A proteins frees E2F, which in turn induces cells into S-phase by transactivation of cellular promoters containing E2F-responsive elements. 1 Free E2F also binds to the inverted E2F binding sites in the viral E2a promoter and induces expression of viral E2 genes that are essential for viral DNA replication and important for viral late gene expression. 2 To prevent the spread of viral infection, host cells have developed several strategies to impede viral replication. One of the well-studied cellular responses is the activation of p53-mediated apoptosis and cell growth arrest. Viral infection induces expression of the p14 ARF gene by the E1A-released E2F and subsequent accumulation of active p53 in the nucleus. High levels of p53 lead to cell growth arrest or apoptosis that is presumed to inhibit viral replication. [3] [4] [5] Adenoviruses (Ad) have developed measures to overcome host cell apoptosis. The E1b-encoded E1B19K and E1B55K proteins protect the infected cells from these E1A-induced p53 effects. E1B55 K binds and inactivates p53 by two mechanisms. First, E1B55K binds to the amino terminus of p53, thus inhibiting p53 transactivation. [6] [7] [8] [9] Second, E1B55K, together with the Ad E4orf6 protein, degrades p53 protein in Ad-infected cells. [10] [11] [12] The E1B19K protein is a functional homologue of the antiapoptotic cellular protein, Bcl-2. It is thought that E1B19K prevents E1A-induced apoptosis by interfering with the actions of the proapoptotic proteins, Bak and Bax. 6, 13, 14 Through the action of these E1b-encoded proteins, premature cell death is prevented and viral replication is maximized.
Ad dl1520 (ONYX-015) with deletion of E1B55K preferably replicates in various tumor cells and have been used in multiple clinical trials. [15] [16] [17] [18] [19] Some reports have supported the hypothesis that dl1520 selectively kills tumor cells harboring a defective p53 gene, 20, 21 while other work by several laboratories found that replication of dl1520 is not determined by p53 status. 18, [22] [23] [24] [25] [26] The mechanisms that underlie cancer selective replication of dl1520 are not well characterized. Since both E1B55K and E1B19K have the same primary goal in repressing apoptosis, it is possible that the intact E1B19K may assume the function of the deleted E1B55K in dl1520. It is also possible that Ad attenuated by mutation in E1a or E1b may generally prefer to replicate in cancer cells because these cells have their cell cycle and apoptosis pathways already altered. Recently, we showed that insertion-mutated E1a can selectively propagate in some cancer cells and destroy tumors in vivo. 27 Studies from J Hay's laboratory have shown that Ad with deletion of either E1B55K or E1B19K can replicate in cancer cells and result in oncolysis. [28] [29] [30] Other studies have demonstrated that a virus deleted for both E1B55K and E1B19K can still replicate in cancer cells, even though it induced more profound apoptosis in comparison to wild-type (WT) adenovirus. 31 Since increased apoptosis will destroy the cellular protein-and DNA-synthesis machineries that are required for virus replication, an important and interesting question is how viruses deleted for the E1b gene can still efficiently replicate in cancer cells.
In the current study, we made a series of deletions in the E1 region and created six viruses, ranging from partial to total deletion of the E1 region. We showed that viruses with deletion of both E1B55K and E1B19K can replicate in cancer cells as efficiently as viruses with deletion of E1B55K alone, while deletions extended from E1b into E1a resulted in forbearance of viral replication in both cancer and normal cells. We demonstrated that E1B19K protein expressed from E1B55K-deleted viruses can efficiently suppress E1A-induced DNA degradation. In addition, we found that although all cancer cells are destroyed by infection with viruses deleted for both E1B55K and E1B19K, cancer cells are killed by two different mechanisms. A fraction of cancer cells infected with viruses deleted for the entire E1B undergoes E1A-induced apoptosis, characterized by chromatin condensation, micronucleus formation, and a broadened nuclear membrane. However, a majority of cancer cells infected with the E1b-deleted viruses supported selective viral replication and produced abundant infectious virus particles. The data in this study suggest that we can combine the two strategies of apoptosis and viral replication into one vector to destroy apoptotic-resistant as well as viral replication-resistant cancer cells.
Materials and methods

Cell lines and cell culture
The 293 cell line is a permanent line of primary human embryonic kidney cells transformed by sheared human Ad type 5 DNA (ATCC, CRL-1573).
32 A549 (ATCC, CCL 185) is human lung carcinoma cell line with WT p53 33 and Hs 181.Sk is normal human skin fibroblast cell line (ATCC, CRL-7129). 293 and A549 cells were grown in aMEM (Gibco, Grand Island, NY) and Hs 181 cells were grown in DMEM (Gibco, Grand Island, NY), both media supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), 100 U of penicillin and 100 mg of streptomycin per ml.
Plasmids and viral vectors
The pBHGE3 plasmid 34 contains Ad genomic DNA. The pBHGE3 has a partial deletion of the E1 region and the essential viral-packaging signal. Plasmid pDE1spA1 is an Ad shuttle plasmid with an E1 deletion from bp 342 to 3523. 34 Both of these Ad plasmids were kindly provided by Dr F Graham.
To prepare vectors with various deletions of the E1 region, we cleaved a segment of 3.3 kb, from bp 342 to 3665 of Ad 5 genome (GenBank Accession No M73260) with restriction enzymes Ssp I and Sph I and then cloned the fragment into plasmid pNEB193 (New England Biolabs, Beverly, MA). The resulting plasmid named pBZ109 contains the entire E1a and most E1b-coding sequences. The DNA fragments containing the viral genome from bp 342 to various sites, bp 1007 (SamI), bp 1339 (XbaI), bp 1572 (HincII), bp 1833 (PstI), and bp 2804 (HindIII), were further cleaved from pBZ109 and inserted into multiple cloning sites in pDE1spA1. This resulted in five plasmids, designated pBZ318, pBZ313, pBZ305, pBZ306, and pBZ307. The Ad DNAs inserted in all these plasmids were documented to contain the appropriate E1 regions by restriction analysis. Cotransfection of pBHGE3 with pDE1spA1, or pBHGE3 with each of these 5 pDE1spA1 derivative plasmids, into 293 cells resulted in six Ad with various deletions of the E1 region. The E1 regions of the viruses with partial and total deletions are depicted (Fig 1) .
Western blot, virus titer and viral DNA replication assay A549 cells were infected with various viruses at a multiplicity of infection (MOI) of 10. Cells were harvested at 24 hours after infection and lysed in a lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) with a proteaseinhibitor cocktail containing 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), pepstatin A, transepoxysuccinyl-lleucylamido(4-guanidino)butane(E-64), bestatin, leupeptin, and aprotinin (10 ml/10 6 cells; Sigma, St Louis, MO) for 30 minutes. Cell lysates were centrifuged, and protein concentration was determined by BIO-RAD DC protein assay (BIO-RAD, Hercules, CA). Equal amounts (30 mg) of cellular protein were electrophoresed in SDSpolyacrylamide gels and transferred to a Hybond-PVDP membrane (Amersham, Arlington Heights, IL). The membrane was incubated with the primary antibodies diluted in phosphate-buffered saline (PBS) containing 0.5% BSA and 0.1% Tween-20. Purified mouse antiadenovirus type 5 E1A monoclonal antibody (BD Biosiences, San Diego, CA) was diluted 1:500; purified mouse anti-adenovirus type 2 E1B 19K monoclonal antibody Ab-1 (Oncogene, Boston, MA) was diluted at 1:50. Binding of the primary antibody was detected using a secondary antibody, anti-mouse immunoglobulin (Ig) conjugated to horseradish peroxidase (Amersham, Arlington Heights, IL). ECL reagents were used to detect the signals according to the manufacturer's instructions (Amersham, Arlington Heights, IL). Plaque purification and titer determination were performed in six-well plates using 293 cells as described previously. 35, 36 Plaques assay was also carried on A549 cells as performed in 293 cells. Viral DNA replication assay is carried out as reported before. 27 Briefly, A549 cells were infected with WT Ad, Adhz23, Adhz60, Adhz62, Adhz63, Adhz64, or Adhz65 at an MOI of 1. After 4 hours of infection, the unabsorbed viral particles in the media were removed and fresh medium was added. The infected cells were collected at days 0 (4 hours), 1, 2, and 3 after infection. The total DNAs were isolated from collected cells and applied on agarose gel for Southern blot analysis.
DNA fragmentation assay and transmission electron microscopy
Near-confluent A549 cancer cells in 60-mm dishes were infected with WT and several mutant Ad vectors at 50 plaque forming unit (PFU)/cell. At 24 hours after infection, the medium was removed, and the attached cells were gently trypsinized, both the floating and attached cells were collected by centrifugation, and washed in 200 ml of PBS. The DNA was isolated using Quick Apoptotic DNA Ladder Detection Kit (BioVision Inc., Mountain View, CA) according to the instruction of the provider. The DNA extracted has been examined on 1.5% agarose gel and stained with ethidium bromide.
To study virus replication and the associated subcellular structural changes, A549 cells were grown to about 70% confluence in 10-cm dishes before infection with E1b-deleted virus Adhz60 or WT Ad at an MOI of 50. After 4 hours incubation at 371C, unattached viruses were removed and cultures refed with fresh medium. After 24 or 48 hours, cells were washed, trypsinized, and fixed in 3.7% buffered formalin for 5 minutes. The suspended cells were spun for 5 minutes at 500 rpm. The resulting cell pellets were fixed for an additional day at 41C before processing for transmission electron microscopy as described earlier. 37 Polymerized blocks were sectioned at 1 mm and stained with toluidine blue for light microscopic evaluation. Subsequently, they were sectioned at 800 Å , and stained with lead citrate and urylnal acetate before being examined in a Philips CM 10 electron microscope.
Results
Expression of E1A and E1B from Ad vectors with various deletions in E1 regions
Homologous recombination within 293 cells between the pBHGE3 and each of the six shuttle plasmids described in Materials and methods introduced the deleted E1 region into Ad genome. In all, we developed six Ad vectors: Adhz23, Adhz60, Adhz62, Adhz63, Adhz64, and Adhz65 (Fig 1a) . In Adhz23, both E1a and E1b genes were deleted. Adhz64 and Adhz65 contained deletion of the entire E1b and partial E1a. Adhz60 kept the WT E1a, but had a deleted E1b gene including its promoter; Adhz60 also was deleted in the poly (A) site for the E1a gene. , and Adhz63, all containing intact E1a coding region. Partial (Adhz64 and Adhz65) and total (Adhz23) deletion of E1a resulted in no detectable E1A proteins as the mock control. Only with Adhz63 remaining, the E1B19K gene produced this protein as the WT control, while all the other viruses were partially or entirely deleted the E1B19K. a-Actin was used as a control to demonstrate an equal loading and transfer.
E1A-induced apoptosis X-M Rao et al
Adhz62 had deleted most of the E1b, inactivated for both the E1B55K and E1B19K. Adhz63 was deleted from bp 2804 to 3523, deleted only E1B55K as dl1520. The deletions of the E1a and E1b regions in all these viruses are depicted in Figure 1 , with the WT Ad E1 regions at the top. With deletions of E1a and E1b regions, expression of the E1 genes from these vectors will depend on the remaining genes. To assess expression of E1a and E1b from these vectors, we infected A549 at an MOI of 10 and, 24 hours later, prepared protein samples for Western blot analysis (Fig 1b) . Multiple species of E1A proteins were produced from WT virus, ranging in size from approximately 30-50 kDa. The antibody against E1A labeled three prominent bands in WT due to different splicing of E1a transcripts. Adhz60 with deletion of bp 1572-3523, including the E1a gene poly (A) signal at bp 1630, produced higher levels of the 12S protein, the second band (Fig 1b) . Figure 1a .
E1b-deleted viruses form plaques in cancer cells
A549 cancer cells were infected with WT and E1-deleted viruses at an MOI of 1. Cytopathic effects (CPE) in A549 cells were observed in 2-3 days after infection with WT Ad, Adhz60, Adhz62, and Adhz63. By contrast, Adhz64 and Adhz65 (with deletion of E1b and partial E1a) and Adhz23 (with deletion of both E1a and E1b) did not cause CPE in A549 cells. To determine whether the CPE is caused by virus replication or direct consequence of viral particle toxicity, we carried out plaque assay. The plaque assay is based on the ability of a single infectious viral unit (or particle) to replicate and give rise to a macroscopic area of cytopathology on a monolayer of cultured cells. Only a viral unit that can produce multiple infectious virions within a single infected cell and release these viral particles from the infected cell for further infection can form plaque on a monolayer of cells. WT Ad, Adhz60, Adhz62, and Adhz63 formed plaques in A549 cells at days 4-5. At day 6, the plaques typically covered an entire microscopic field using Â 40 objective (Fig 2a) . (Fig 2b) .
E1b-deleted virus replication in cancer cells
The inability of the E1a-and E1b-deleted vectors to induce CPE and to form plaques on A549 cells may be due to a lack of viral genome DNA replication. To Fig 3) ; all the three vectors are deleted E1b plus partial or entire E1a (Fig 1) . Viral DNA replication was observed in cells infected with the E1b-deleted Adhz60, Adhz62, and Adhz63. There is no difference among the viruses with deletion of only E1B55K or both E1B55K and E1B19K (Fig 3) .
To compare the titers of viruses propagated in A549 cells, we used WT Ad5, Adhz23, Adhz60, Adhz62, Adhz63, Adhz64, and Adhz65 to infect the cells. The titer of the E1b-mutated vectors increased about 1000-fold during 3 days of infection. However, the titers of Adhz23, Adhz64, and Adhz65 were even lower than the titer of virus added for infection (as indicated with a dashed line in Figure 4a ). The titers of E1b-deleted Adhz60, Adhz62, and Adhz63 were similar to that of WT Ad. The above experiment determined the final yields of various vectors. To follow viral growth kinetics in cancer cells, A549 cells were also infected at an MOI of 1 with the WT Ad, Adhz23, Adhz60, Adhz62, and Adhz63. We did not include Adhz64 and Adhz65 in this experiment because the above studies already showed that there was no viral replication of the two E1a-and E1b-deleted viruses. The total cells were collected at days 0, 1, 2, and 3 for titer. The titers for all three E1b-deleted viruses were increased to the titer similar to WT virus (Fig 4b) . These studies clearly demonstrated that virus with deletion of entire E1b can replicate as efficiently as viruses with deletion of only E1B55K.
In addition, we also observed replication and cytopathic effect (CPE) of Adhz60 in liver cancer cells Hep3B and HepG2, breast cancer cells MD435 and MCF7, skin cancer cells SK MEL2 and SK MEL28, and prostate cancer cells LNCap; while the replication is limited in prostate cancer cells PC-3 (Fig 5) . 
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E1A-induced DNA degradation is inhibited by E1B19K
Adenoviral E1A proteins activate apoptotic pathways that lead to cell death and inhibition of viral replication. E1B55K can inhibit p53-mediated apoptosis. It was proposed that dl1520 deleted for E1B55K can selectively replicate in p53-mutated cancer cells because these cells are defective in p53-dependnent apoptotic pathways, therefore allowing the virus to replicate. However, several studies have shown that dl1520 replication is not determined by p53 status in cancer cells. 18, [22] [23] [24] [25] [26] A primary question is how apoptosis is induced by E1b-deleted viruses and how viruses with deletions of E1b could replicate in cancer cells.
We studied apoptosis of cancer cells infected with various viruses by using a DNA fragmentation assay. At 24 hours after infection, cellular DNA was isolated from cancer cells. The DNA samples were examined on agarose gel. Only the viruses (Adhz60 and Adhz62) with WT E1A and deletions of both E1B19K and E1B55K caused DNA degradation (Fig 6) . DNA degradation was not observed in cells infected with viruses (Adhz23, Adhz65, and Adhz64) with mutated E1A. DNA degradation was also blocked in cells infected with Adhz63, which is similar to dl1520 in that it contains intact E1B19K but is deleted for E1B55K. The data demonstrate that Ad E1A protein can efficiently induce DNA degradation and E1A-induced DNA degradation is significantly inhibited by E1B19K.
Virus deleted both E1B55K and E1B19K destroyed cancer cells by apoptosis and selective replication
Infections with Adhz60 and Adhz62 could lead to degradation of DNA in cancer cells, but the DNA is not fragmented as in typically apoptotic cells. We wished to further understand how the viruses deleted for E1B19K and E1B55K could produce infectious progeny in these ''apoptotic'' cells. To address this question, we examined individual cells infected with Adhz60 by electron microscopy. A549 cells were harvested 24 and 48 hours postinfection with Adhz60 at 50 MOI, at that virus level almost all cells are infected. Viral particles were rarely found in cells infected with Adhz60 at 24 hours. At that time point, we observed that 26 out of 156 cells (16.7%) displayed condensed chromatin and multiple micronuclei, apoptotic hallmarks (Table 1 and Figure 7a ). The nuclear membrane in these cells were broadened and lightly strained (Fig 7a, b) , presumably because of liquid flow into the nuclear membranes. These cells, which showed typical characteristics of apoptosis, did not produce viral particles at 48 hours (Fig 7b) . However, the majority of cells (83.3%) infected with Adhz60 contained a single nucleus (Fig 7c, d) and produced large patches of viral particles at 48 hours (Fig 7d) . Unlike the cells infected with E1B-deleted Adhz60, cancer cells infected with WT Ad produced abundant viral particles and only one out of 150 cells showed condensed chromatin or multiple micronuclei (Table 1 ). This study suggested that although 
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Degraded Figure 6 DNA fragmentation analysis of A549 cells infected with WT and mutant Ad virus. A549 cells were infected with WT or mutant Ad virus at 50 PFU/cell. At 24 hours after infection, the DNA was isolated using Quick Apoptotic DNA Ladder Detection Kit and was examined on 1.5% agarose gel stained with ethidium bromide.
E1A-induced apoptosis X-M Rao et al a small fraction of cells infected with Adhz60 undergoes apoptosis, the majority of cells are able to allow viruses to complete their infectious life cycle. This experiment also helps to explain why there was only partial DNA degradation in A549 cells after infection with Adhz60 (Fig 6) . The above experiments suggest that viruses with deletion of both E1B55K and E1B19K can destroy cancer cells by either apoptosis or selective replication.
Discussion
Adenoviral infection activates p53 which would lead to cell growth arrest and apoptosis before the viral life cycle has been completed. 4, 5 Adenovirus dl1520, with deletion of E1B55K, selectively replicates in cancer cells presumably because of p53 deficiency in these cells. 20, 21 However, recent studies showed that dl1520 could also replicate in cells expressing WT p53. 18, [22] [23] [24] [25] [26] The mechanism for dl1520-selective replication in cancer cells is not well studied. In this study, we showed that infection with viruses deleted for both E1B19K and E1B55K resulted in cellular DNA degradation. However, cells infected with Adhz63, which is deleted for only E1B55K (similar to dl1520), did not generate fragmented DNA (Fig 6) . The results suggest that E1B19K alone can efficiently inhibit E1A-induced apoptosis. E1B19K is a Bcl-2 homologous oncogene that can block p53-dependent and -independent apoptosis, 6, 13 that may help to explain why dl1520 with intact E1B19K can replicate in both p53-WT and p53-mutated cancer cells. We also found that infection with Adhz60 and Adhz62 (deleted for both E1B19K and E1B55K) led to cellular DNA degradation, a sign of apoptosis (Fig 6) , but these viruses still can replicate in cancer cells (Fig 3) . These results agree with previous studies of adenoviruses with deletion of E1B55K or E1B19K, [28] [29] [30] or both E1B55K and E1B19K that can still replicate in cancer cells. 31 An important question is how viruses replicate in cancer cells when their apoptotic pathways should already be activated by viral E1A proteins. With electron microscopy, we have studied individual virus-infected cells. We found that about 17% of cancer cells infected by Adhz60 underwent complete apoptosis and aborted viral reproduction, while the majority of cells allowed virusselective replication, resulting in the production of abundant viral progeny (Figs 3 and 7) . We do not know why only small fraction of the total infected cells undergo complete apoptosis, while the rest of the cells allow the virus to replicate. Cancer cells even from the same cell line may be heterogeneous in culture. Through analysis of unselected subclones, cultured HCT116 cells are found containing mixture alleles of Bax þ / þ , À/ þ and À/À.
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The BaxÀ/À cells are defective in manifestation of apoptosis induced by multiple stimuli. 39 It is possible that some of the cultured A549 cancer cells may gain or lose apoptotic factors. It is also possible that some infected cancer cells may be in a cell cycle, such as Sphase, when apoptotic pathways may be ready to be activated. Further studies should focus on how cancer cell apoptotic factors and cell cycle regulations affect virus selective replication and oncolysis.
It is generally believed that the major function of adenovirus E1B proteins is to inhibit p53-dependent and -independent apoptosis. However, studies from our laboratory and others have shown that viruses with partial or entire deletion of the E1b gene fail to induce apoptosis in most cells (normal or cancer cells), and fail to inhibit virus replication in most tested cancer cells regardless of p53 status. Therefore, a tentative assumption is that E1B proteins may have other important functions in the viral life cycle in addition to repressing apoptosis. By using E1B55K-deleted Ad338, Hay et al 28 have shown that an important role of E1B55K is to control host cellular protein shutoff. Recently, we also found that viral E1b products have functions in the regulation of host cellular gene 27 In the current study, we also observed that the E1b-deleted Adhz60 can replicate in various cancer cells, but not in PC-3 cells (Fig 5) . Other studies have shown that dl1520 could not replicate or replicated poorly in U2Os, PC-3, and Saos-2 cells. 24 Since cancer cells are highly heterogeneous in tumors of patients; some cancer cells may support viral replication, while other cancer cells may be resistant to virus replication. The existence of virus replication-resistant cancer cells in patients may be one of the reasons for the limited efficacy of dl1520 in clinical trials.
Other clinical trials have used the E1a gene to induce apoptosis in cancer cells. In a number of studies, E1A protein encoded in a plasmid was shown to reduce tumor growth and to induce apoptosis in cancer cells. [40] [41] [42] [43] [44] Owing to promising preclinical data, Phase I and Phase II human clinical trials have been conducted involving E1A delivery to ovarian, breast, or head and neck tumors. 45, 46 However, the E1A protein, as single anticancer agent, has a limited efficacy in these trials, possibly because some cancer cells in tumors are resistant to E1A-induced apoptosis.
We believe that any single agent, even if it may be efficient for destroying cancer cells in vitro or tumors formed in animals from a cell line, may not work efficiently in clinical treatments, because cancer cells in patient tumors are highly heterogeneous. These clinical trials using the viral E1a gene or Ad dl1520 demonstrate the potential of these novel treatment platforms, as well as the urgent need to combine different strategies to enhance cancer molecular therapy.
We have shown that Adhz60 combined the two strategies -inducing apoptosis and virus-selective replication -into one vector. Our study suggests that by using Adhz60 or further developed vectors, cancer cells that are resistant to viral replication may be destroyed by virus-induced apoptosis, while cells that are resistant to apoptosis could allow the virus to replicate and be killed as a consequence of viral replication. Eventually, all cancer cells can be destroyed. Deletion of the entire E1b region provides 2 kb space for the potential use of a large regulatory element to control E1a expression for highly selective virus replication in cancer cells.
